Article
Profilin-1 Promotes Chromophobe Renal Cell Carcinoma Malignancy
2026-05-14
Abstract excerpt
<h4>ABSTRACT</h4> Chromophobe renal cell carcinoma (ChRCC) accounts for 5% of all renal cancer cases. Despite its generally indolent behavior and low mutational burden, there is no targeted therapy for metastatic ChRCC. Profilin-1 (Pfn1), a cytoskeletal regulator of actin and tubulin dynamics, has emerged as a potential oncogenic driver in several cancers including RCC, but its role in ChRCC, remains undefined. W...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 04556597-981d-5f67-8edd-3c9d4abb427c
- DOI
- 10.64898/2026.05.11.723846
